- Efficacy of Roflumilast in Bronchiectasis Patients with Frequent Exacerbations: A Double-Blinded, Randomized, Placebo-Controlled Pilot Clinical Trial
-
Juthong S, Panyarath P
- KMID: 2523545
- Tuberc Respir Dis.
- 2022 Jan;85(1):67-73.
- doi: 10.4046/trd.2021.0051
Background: Bronchiectasis patients with neutrophilic airway inflammation develop symptoms of chronic cough, sputum production, and recurrent exacerbations. Roflumilast has anti-inflammatory actions via decreased neutrophilic airway inflammation. The effectiveness of roflumilast... -
- CITED
-
- Close
- SHARE
-
- Close
